Targeting the PI3K/Akt/mTOR pathway: A therapeutic strategy in COVID-19 patients

Authors: Abu Eid, Rasha ;

Ward, Frank James

Source: Immunology Letters

Full text

: https://doi.org/10.1016/j.imlet.2021.09.005

Abstract

Rights

The manuscript version is made available on the University of Aberdeen Repository under the CC-BY-NC-ND 4.0 license: https://creativecommons.org/licenses/by-nc-nd/4.0/.

Cite as

Abu Eid, R. & Ward, F. 2021, 'Targeting the PI3K/Akt/mTOR pathway: A therapeutic strategy in COVID-19 patients', Immunology Letters, 240, pp. 1-8. https://doi.org/10.1016/j.imlet.2021.09.005

Downloadable citations

HTML BIB RIS

Identifiers

DOI: https://doi.org/10.1016/j.imlet.2021.09.005

Repository URI: https://hdl.handle.net/2164/19216